Stay updated with breaking news from Microenvironment Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Ze'ev Ronai, PhD, discusses key advancements in the treatment of patients with melanoma, including the discovery of NRAS and BRAF mutations, as well as the development of immunotherapy approaches.
Study of cell exhaustion in immunotherapy-resistant tumors could significantly improve the benefits of cancer immunotherapy for patients with treatment resistant types of cancer.
The new technique, which was just published in Cell Reports, can reduce T cell fatigue even in cancers that are resistant to clinically approved immunotherapies. It can also keep T cells from becoming exhausted.
When the immune system's T cells are constantly stressed as a result of cancer or other chronic diseases, they suffer a process known as T cell fatigue
He immune system's T cells undergo a process known as T cell exhaustion when they are constantly stressed out as a result of cancer or other chronic disorders. Without functioning T cells, which destroy tumour cells, our bodies are unable to combat cancer. In order to increase the immune system's capacity to eliminate malignant cells, one of the main objectives of immunotherapy is to reverse T cell fatigue.